Study Group (n = 31) Study Group (n = 31) Control Group (n = 33) Control Group (n = 33) p-value p-value
Chemotherapy regimens of 3rd line Chemotherapy regimens of 3rd line
Carboplatin based Carboplatin based 13 (39.4%) 13 (39.4%)
Nedaplatin based Nedaplatin based 8 (24.2%) 8 (24.2%)
Cisplatin based Cisplatin based 1 (3.0%) 1 (3.0%)
Oxaliplatin based Oxaliplatin based 1 (3.0%) 1 (3.0%)
Lobaplatin based Lobaplatin based 4 (12.1%) 4 (12.1%)
Multiple platinum Multiple platinum 6 a(18.2%) 6 a(18.2%)